Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03UUL
|
|||
| Former ID |
DNCL001728
|
|||
| Drug Name |
APN01
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04] | Phase 1 | [1] | |
| Myocardial infarction [ICD-11: BA41-BA43] | Phase 1 | [1] | ||
| Company |
Apeiron Biologics; GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00886353) Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.